MDMA for PTSD: Setback Sparks New Battle Plan

August 14, 2024

Fluence, Enthea Partner to Expand Access for Ketamine-Assisted Therapy

July 7, 2024

Analysis: MDMA Setback Shows Psychedelic Medicine Still Has Work Ahead

June 7, 2024

Optimi Health Receives Regulatory Approval to Export to Australia

June 3, 2024

Lykos Appoints Finance Veteran Scott Giacobello to Board of Directors

May 31, 2024

Concerns Raised About MDMA-Assisted Psychotherapy Trials for PTSD

May 17, 2024